Cancer Center Administration

摘要 伦巴迪综合癌症中心(LCCC)联合政府的使命是促进 并实施LCCC的愿景，创建、支持和维持一个促进研究、互动的环境 为癌症中心研究人员提供最佳的工作效率，并为该中心增加价值。LCCC财团是 由总部设在华盛顿特区的乔治敦隆巴迪综合癌症中心(LCCC-DC)和 Hackensack子午线健康(HMH)的John Theurer癌症中心(JTCC)，总部设在新泽西州Hackensack (LCCC-新泽西州)。支持四个研究计划、九个共享资源和114名成员，专注于基础、 翻译、临床和基于人群的研究，政府监管1357万美元(1198万美元， 158万美元(LCCC-NJ)ADC同行评审资金和2310万美元(LCCC-DC和170万美元) 赠款和合同(直接费用)。Michael Vander Hoek，MHSA，行政副主任(AD)， 领导管理团队，支持LCCC领导层规划、战略投资、标杆、 评估和与选民的沟通。除了建立一支经验丰富的管理团队来 支持癌症中心成员，Vander Hoek管理招募了大量调查人员和 支持他们的教职任命和晋升。他和他的团队成功地管理了机构 承诺支持这些战略举措。政府跟踪和管理LCCC的2.169亿美元 乔治城大学医疗中心(GUMC)、MedStar Health(MH)和HMH的机构投资， 确保投资与LCCC的战略计划相联系。行政部门记录和执行 LCCC关于成员资格、试点资金、设备采购、共享资源和空间的政策。这个 政府还协调癌症研究、教育和培训。行政管理的显著扩展 活动支持了与作为临床合作伙伴的MH和JTCC日益富有成效的关系，JTCC 是LCCC位于新泽西州的临床园区，旨在增加介入试验的收益并增加 参加试验的个体的多样性。例如，行政当局牵头实施OnCore 全企业临床试验管理系统(CTMS)。其他活动在叙述中得到了强调。

ABSTRACT The mission of the Lombardi Comprehensive Cancer Center (LCCC) Consortium’s Administration is to facilitate and implement LCCC’s vision and create, support and sustain an environment that fosters research, interactivity and optimal productivity of Cancer Center investigators and adds value to the Center. The LCCC Consortium is comprised of Georgetown Lombardi Comprehensive Cancer Center, based in Washington, DC (LCCC-DC) and the John Theurer Cancer Center (JTCC) of Hackensack Meridian Health (HMH), based in Hackensack, NJ (LCCC-NJ). Supporting four Research Programs, nine Shared Resources and 114 members focused on basic, translational, clinical and population-based research, the Administration oversees $13.57M ($11.98M LCCC-DC, $1.58M LCCC-NJ) ADC in peer-reviewed funding and $23.1M ($21.4M LCCC-DC, $1.7M LCCC-NJ) in other grants and contracts (direct costs). Michael Vander Hoek, MHSA, Associate Director (AD) for Administration, heads the administrative team, supporting LCCC leadership planning, strategic investments, benchmarking, evaluation and communication with constituencies. In addition to building an experienced management team to support Cancer Center members, Vander Hoek managed the recruitment of numerous investigators and supported their faculty appointments and promotions. He and his team have successfully managed institutional commitments to support these strategic initiatives. The Administration tracks and manages LCCC’s $216.9M in institutional investments from Georgetown University Medical Center (GUMC), MedStar Health (MH) and HMH, ensuring that investments are linked to LCCC’s strategic plan. The Administration documents and executes LCCC’s policies on membership, pilot funding, equipment purchases, Shared Resources and space. The Administration also coordinates cancer research education and training. Significant expansion of administrative activities has supported an increasingly productive relationship with MH, as a clinical partner, and JTCC, which is LCCC’s clinical campus in New Jersey, aimed at increasing accrual to interventional trials and increasing the diversity of individuals enrolling in trials. For example, the Administration led the implementation of the OnCore enterprise-wide Clinical Trial Management System (CTMS). Other activities are highlighted in the narrative.